First Bi-Directional Interface Between a Lab Information System (LIS) and a Digital Pathology Cockpit Creates a Single Immersive Environment for Pathologists to Review Cases and Report Diagnostic Findings

Washington, DC, Oct. 09, 2017 (GLOBE NEWSWIRE) — Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc.and Lab Information System (LIS) company SCC Soft Computer announced today that they have successfully developed a bi-directional interface between the SCC LIS and Inspirata’s Digital Pathology Cockpit. The result is the first fully immersive environment where pathologists can comprehensively review patient cases, diagnose diseases, write diagnostic reports and submit those reports to the LIS.

The interface was built using Inspirata’s HL7-compliant Enterprise Service Bus (ESB) that facilitates straightforward re-use of data between systems. It communicates through SCC’s SoftPathDx module, which is the diagnostic pathology support system in the LIS.

“Without this interface, pathologists must access patient history, case information and relevant diagnostic imaging reports from siloed systems,” explains Inspirata Executive Vice President and Founder, Mark Lloyd, PhD, MSM. “Essentially, a pathologist is like a detective; the more clues they can assemble about a patient, the more confident they can be in the diagnosis they must make from the tissue samples they are given to examine.

“We see this interface as a major step in streamlining the diagnostic workflow, and we’re looking forward to demonstrating it to the pathologists attending CAP,” continues Dr. Lloyd. “Providing data feeds from separate information systems in a single immersive environment like our Digital Pathology Cockpit will enable pathologists to focus on diagnosing the patient’s disease rather than searching for and retrieving information from disparate diagnostic systems.”

“As the world’s largest LIS vendor, we are extremely pleased to add the distinction of being the first and only LIS vendor to partner with a company like Inspirata to enable seamless bi-direction data exchange between an LIS and a single-sign-on Digital Pathology Cockpit,” says Gilbert Hakim, founder and CEO of SCC Soft Computer. “This interface will accelerate pathologists’ decision making by eliminating the cumbersome process of logging into separate systems and, at the same time, retain the LIS as the system of record for the final diagnostic report.”

According to Inspirata CEO Satish Sanan, “This interface is an industry milestone because LIS vendors have traditionally maintained very closed systems, which actually hamper the diagnostic workflow. Thanks to SCC’s willingness to partner with us on this initiative, hospitals and cancer centers using both of our systems will have a much more efficient and seamless workflow.”

About SCC Soft Computer

The world’s largest LIS vendor, SCC Soft Computer is at the forefront of laboratory, genetics, outreach, and blood services information systems software development. Committed to supplying innovative technologies, SCC designs, develops, and delivers full suites of integrated laboratory and genetics information management system solutions for hospitals, large IDNs, and laboratories. Visit for more information.

About Inspirata, Inc.

Inspirata®, Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit or contact